Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Urine protein marker for asthma and application thereof

A protein, asthma technology, applied in the field of clinical medicine

Inactive Publication Date: 2021-01-05
BEIJING NORMAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There is currently no precise diagnostic test for asthma, usually based on the type of symptoms, response to treatment over time, and spirometry. For details, see Unknown Author, Chinese Guidelines for the Prevention and Treatment of Bronchial Asthma (Grassroots Edition)—Diagnosis and Analysis of Bronchial Asthma Differential diagnosis [J]. Chinese General Medicine, 2013, 16(31): 3030-3030

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Urine protein marker for asthma and application thereof
  • Urine protein marker for asthma and application thereof
  • Urine protein marker for asthma and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042]Example 1. Establishment of asthma model

[0043]Take 6-8 weeks old male C56BL / 6 mice, 3 mice in the experimental group and 6 mice in the control group. On day 0 and day 7, intraperitoneal injection of 200uL emulsion (containing OVA: 50ug; Alum: 2mg) was sensitized ; After sensitization, drip the nose from the 14th day to the 16th day, anesthetize the mice with ether and then drip 50ul (including OVA: 50ug). In this example, the inventors injected ovalbumin (OVA) and nasal drops into mice to create a model to simulate asthma. Urine was collected for analysis in the early, early and late stages of asthma.

[0044]1. Materials and reagents

[0045]1) Instrument:

[0046]Orbitrap Fusion Lumos Tribird mass spectrometer was purchased from Thermo Scientific; mouse metabolic cage: purchased from Beijing Jiayuan Xingye Technology Co., Ltd.

[0047]2) Main reagents:

[0048]Chromatography mass spectrometry grade water, acetonitrile, formic acid and methanol were purchased from Fisher; Iodoacetylammonium...

Embodiment 2

[0054]Example 2. Urine sample collection and protein identification

[0055]1. Urine sample collection:

[0056]After modeling, the experimental group and control group mice were placed in metabolic cages to collect urine on the 2, 7, 10, 14, and 17 days.

[0057]2. Extraction of protein in urine by ethanol precipitation

[0058]A total of 15 urine samples from 3 mice on days 2, 7, 14, 17 and 3 control mice were taken to extract protein for subsequent analysis. The method of ethanol precipitation of urine protein refers to the method of Sun W et al. (see Sun W et al. Proteomics, 2005, 5(18):4994-5001).

[0059]The specific steps are:

[0060]1) Take the mouse urine stored in the refrigerator at -80℃, thaw it at 37℃, centrifuge the urine after thawing: take 0.4mL, 12000g, 4℃, centrifuge for 10min; save the supernatant.

[0061]2) Precipitating protein: Add pre-cooled ethanol (1:4) to the retained supernatant, the total volume is about 2 mL.

[0062]3) In the refrigerator at 4°C overnight (-20°C, 2h).

[0063]4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a urine protein marker for asthma and application thereof. The present application relates to the application of a urine protein marker selected from a group consisting of epidermal growth factor receptor substrate 15, Cathelicidin antimicrobial peptide, haptoglobin, alpha-1-acidic glycoprotein 1, prolactin-inducing protein homolog, odorant binding protein 2a, protein LEG1homolog, complement factor B, retinoid beta, beta-2 microglobulin, prothrombin, eosinophilic granulocyte cationic protein 1, protein AMBP, plasminogen, a procollagen C-endopeptidase enhancer 1, a sodium channel and gridding protein connecting agent 1 and vitamin D binding protein. According to the application, an animal model for screening the asthma-related urine protein marker is established, the asthma-related urine protein marker is obtained by using the established animal model, and an application of a detection reagent of the marker in preparation of a kit for diagnosing asthma of a subject is also established.

Description

Technical field[0001]The present invention relates to the field of clinical medicine; specifically, the present invention relates to a urine protein marker related to asthma. Specifically, the present invention relates to obtaining urine protein markers related to asthma by using a mouse model of asthma and mass spectrometry urine proteomics technology, and the use of the urine protein markers.Background technique[0002]Asthma is a chronic inflammatory airway disease caused by a combination of genetic and environmental factors. See Martinez F.D. Genes, environments, development and asthma: a reappraisal. European Respiratory Journal. 2007.29(1): 179-184. It is characterized by airway inflammation leading to restricted expiratory airflow, the intensity of which changes over time. Symptoms include wheezing, shortness of breath, chest tightness, and cough, see GINA.Global strategy for asthma management and prevention.Global Initiative for Asthma.2017.The updated asthma guidelines from G...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/68G01N30/02G01N30/06G01N30/72G01N30/88
CPCG01N30/02G01N30/06G01N30/7233G01N30/88G01N33/68G01N33/6848G01N2030/027G01N2030/8831G01N2560/00G01N2800/122
Inventor 高友鹤刘光伟王婷
Owner BEIJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com